FeNO
The fractional exhaled nitric oxide (FeNO) test measures the level of NO in the exhaled breath and provides an indication of eosinophilic inflammation in the lungs.
A PCRS Consensus: FeNO testing for asthma diagnosis
The fractional exhaled nitric oxide (FeNO) test measures the level of NO in the exhaled breath and provides an indication of eosinophilic inflammation in the lungs.
Guide to FeNO Testing
In this article produced for Practice Nurse, author, PCRS Chair, Carol Stonham, describes FeNO testing and its role in diagnosing respiratory disease. She discusses the advantages and limitations of this test.
FeNO for the diagnosis and management of asthma
Resources from the Academic Health Science Network (AHSN) Programme
Ardens, providers of TPP SystmOne and EMIS Web templates and resources, have created templates to support the use of FeNO testing.
Resources from the Academic Health Science Network (AHSN) Programme
In this article produced for Practice Nurse, author, PCRS Chair, Carol Stonham, describes FeNO testing and its role in diagnosing respiratory disease. She discusses the advantages and limitations of this test.
On the 6 February, NHS England issued an update to the GP contract agreement 2020/21 to 2023–23/24. The update includes important improvements to the asthma and COPD domains.
The fractional exhaled nitric oxide (FeNO) test measures the level of NO in the exhaled breath and provides an indication of eosinophilic inflammation in the lungs.